Literature DB >> 4287115

Assessment of hypothalamic pituitary function in endocrine disease.

F C Greenwood, J Landon.   

Abstract

The insulin test carried out with adequate safeguards under standardized conditions yields valuable information regarding hypothalamic and pituitary function when plasma levels of sugar, cortisol, and growth hormone are determined. The use of a test based on the plasma cortisol response to the infusion of lysine-vasopressin, a polypeptide with a corticotrophin-releasing action, is also of value as a test of pituitary function. Used in conjunction with the insulin test it enables pituitary disorders to be differentiated from those involving the hypothalamus.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4287115      PMCID: PMC473256          DOI: 10.1136/jcp.19.3.284

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  22 in total

1.  HUMAN GROWTH HORMONE. CLINICAL MEASUREMENT, RESPONSE TO HYPOGLYCEMIA AND SUPPRESSION BY CORTICOSTEROIDS.

Authors:  A G FRANTZ; M T RABKIN
Journal:  N Engl J Med       Date:  1964-12-31       Impact factor: 91.245

2.  IMMUNOASSAY OF HUMAN GROWTH HORMONE IN PLASMA.

Authors:  S M GLICK; J ROTH; R S YALOW; S A BERSON
Journal:  Nature       Date:  1963-08-24       Impact factor: 49.962

3.  RADIOIMMUNOASSAY OF HUMAN PLASMA ACTH.

Authors:  R S YALOW; S M GLICK; J ROTH; S A BERSON
Journal:  J Clin Endocrinol Metab       Date:  1964-11       Impact factor: 5.958

4.  PLASMA GROWTH HORMONE RESPONSE TO INTRAVENOUS ADMINISTRATION OF AMINO ACIDS.

Authors:  R F KNOPF; J W CONN; S S FAJANS; J C FLOYD; E M GUNTSCHE; J A RULL
Journal:  J Clin Endocrinol Metab       Date:  1965-08       Impact factor: 5.958

5.  Control of plasma concentrations of adrenocortical hormones.

Authors:  F E YATES; J URQUHART
Journal:  Physiol Rev       Date:  1962-07       Impact factor: 37.312

6.  Clinical application of a new test of pituitary reserve.

Authors:  G W LIDDLE; H L ESTEP; J W KENDALL; W C WILLIAMS; A W TOWNES
Journal:  J Clin Endocrinol Metab       Date:  1959-08       Impact factor: 5.958

7.  A radio-immunoelectrophoretic assay for human growth hormone.

Authors:  W M Hunter; F C Greenwood
Journal:  Biochem J       Date:  1964-04       Impact factor: 3.857

8.  Test for pituitary function using vasopressin.

Authors:  G Gwinup
Journal:  Lancet       Date:  1965-09-18       Impact factor: 79.321

9.  Plasma-growth-hormone levels in untreated acromegaly and after radioactive implants into the pituitary.

Authors:  F C Greenwood; H J Stewart; A P Forrest; R G Wood
Journal:  Lancet       Date:  1965-09-18       Impact factor: 79.321

10.  Hypoglycemia: a potent stimulus to secretion of growth hormone.

Authors:  J ROTH; S M GLICK; R S YALOW
Journal:  Science       Date:  1963-05-31       Impact factor: 47.728

View more
  8 in total

1.  The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man.

Authors:  A J Garber; P E Cryer; J V Santiago; M W Haymond; A S Pagliara; D M Kipnis
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

2.  [Regulation of somatotropin secretion: attempted unitary interpretation].

Authors:  R Vigneri; S Squatrito; L Motta; V Pezzino; P Polosa
Journal:  Acta Diabetol Lat       Date:  1973 Jan-Feb

3.  Endocrine disturbances in childhood obesity: growth-hormone and cortisol response to insulin induced hypoglycemia.

Authors:  J Girard; M Stahl; P W Nars; J B Baumann
Journal:  Klin Wochenschr       Date:  1972-07-15

4.  Blood-glucose, plasma-insulin and growth hormone concentrations of individuals with minor abnormalities of glucose tolerance.

Authors:  C N Hales; F C Greenwood; F L Mitchell; W T Strauss
Journal:  Diabetologia       Date:  1968-03       Impact factor: 10.122

5.  Hypothalamic and pituitary injury.

Authors:  C S Treip
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1970

6.  Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.

Authors:  R A Rizza; P E Cryer; J E Gerich
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

7.  Growth hormone secretion during sleep.

Authors:  Y Takahashi; D M Kipnis; W H Daughaday
Journal:  J Clin Invest       Date:  1968-09       Impact factor: 14.808

8.  Copeptin as a marker of an altered CRH axis in pituitary disease.

Authors:  Krzysztof C Lewandowski; Andrzej Lewiński; Elżbieta Skowrońska-Jóźwiak; Katarzyna Malicka; Wojciech Horzelski; Georg Brabant
Journal:  Endocrine       Date:  2017-08-09       Impact factor: 3.633

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.